Synergistic Effects of Antimycobacterial Drug Combinations on Mycobacterium Avium Complex Determined Radiometrically in Liquid Medium

Overview

Journal Eur J Clin Microbiol

Specialty Microbiology

Date 1987 Oct 1

PMID 3436314

Citations 29

Authors

S E Hoffner

S B Svenson

G Kallenius

Affiliations

Soon will be listed here.

Abstract

A technique to determine the effects of combining antimycobacterial drugs in liquid medium employing the radiometric growth readings in the Bactec system was tested using 20 Mycobacterium avium complex strains. Ten of the strains had been isolated from children with lymphadenopathy and ten from adults with pulmonary disease. All isolates were resistant to streptomycin, rifampicin, isoniazid and ethambutol when tested with a conventional resistant ratio technique on Löwenstein-Jensen medium. Synergistic interactions were shown for the two-drug combinations streptomycin + ethambutol and ethambutol + rifampicin against all 20 strains. Good efficacy was also found for all three-drug combinations containing ethambutol. Thus, although most isolates of the Mycobacterium avium complex are resistant to first-line antituberculous drugs when tested individually, they are susceptible in vitro to certain combinations of these drugs. This rapid radiometric assay is an efficient means for detecting such synergy.

Citing Articles

Polysaccharide length affects mycobacterial cell shape and antibiotic susceptibility.

Justen A, Hodges H, Kim L, Sadecki P, Porfirio S, Ultee E Sci Adv. 2020; 6(38).

PMID: 32938674 PMC: 7494350. DOI: 10.1126/sciadv.aba4015.

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.

Kim H, Lee J, Kwak N, Cho J, Lee C, Han S BMC Pulm Med. 2019; 19(1):212.

PMID: 31711459 PMC: 6849249. DOI: 10.1186/s12890-019-0982-8.

Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense.

Choi G, Min K, Won C, Jeon K, Shin S, Koh W Antimicrob Agents Chemother. 2012; 56(7):3549-55.

PMID: 22564831 PMC: 3393384. DOI: 10.1128/AAC.00685-12.

Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Harris N, Barletta R Clin Microbiol Rev. 2001; 14(3):489-512.

PMID: 11432810 PMC: 88986. DOI: 10.1128/CMR.14.3.489-512.2001.

First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.

Thorax. 2001; 56(3):167-72.

PMID: 11182006 PMC: 1758783. DOI: 10.1136/thorax.56.3.167.

References

Kiehn T, Edwards F, Brannon P, Tsang A, Maio M, Gold J . Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol. 1985; 21(2):168-73. PMC: 271607. DOI: 10.1128/jcm.21.2.168-173.1985. View

MIDDLEBROOK G, REGGIARDO Z, TIGERTT W . Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media. Am Rev Respir Dis. 1977; 115(6):1066-9. DOI: 10.1164/arrd.1977.115.6.1066. View

Kirihara J, Hillier S, COYLE M . Improved detection times for Mycobacterium avium complex and Mycobacterium tuberculosis with the BACTEC radiometric system. J Clin Microbiol. 1985; 22(5):841-5. PMC: 268539. DOI: 10.1128/jcm.22.5.841-845.1985. View

Nash D, Steingrube V . Selecting drug combinations for treatment of drug-resistant mycobacterial diseases. J Clin Pharmacol. 1982; 22(7):297-300. DOI: 10.1002/j.1552-4604.1982.tb02678.x. View

KUZE F . Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice. Am Rev Respir Dis. 1984; 129(3):453-9. DOI: 10.1164/arrd.1984.129.3.453. View

Davidson P, Khanijo V, Goble M, Moulding T . Treatment of disease due to Mycobacterium intracellulare. Rev Infect Dis. 1981; 3(5):1052-9. DOI: 10.1093/clinids/3.5.1052. View

Hunter A, Campbell I, Jenkins P, Smith A . Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex. Thorax. 1981; 36(5):326-9. PMC: 471504. DOI: 10.1136/thx.36.5.326. View

Wickman K . Clinical significance of nontuberculous mycobacteria. A bacteriological survey of Swedish strains isolated between 1973 and 1981. Scand J Infect Dis. 1986; 18(4):337-45. DOI: 10.3109/00365548609032345. View

CANETTI G, Froman S, Grosset J, HAUDUROY P, Langerova M, MAHLER H . MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE. Bull World Health Organ. 1963; 29:565-78. PMC: 2555065. View

10.

Steadham J, Stall S, Simmank J . Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex. Diagn Microbiol Infect Dis. 1985; 3(1):33-40. DOI: 10.1016/0732-8893(85)90064-1. View

11.

Yeager Jr H, RALEIGH J . Pulmonary disease due to Mycobacterium intracellulare. Am Rev Respir Dis. 1973; 108(3):547-52. DOI: 10.1164/arrd.1973.108.3.547. View

12.

Takahashi H, Foster V . Detection and recovery of mycobacteria by a radiometric procedure. J Clin Microbiol. 1983; 17(2):380-1. PMC: 272644. DOI: 10.1128/jcm.17.2.380-381.1983. View

13.

Kroening U . [In vitro studies on the inhibitory effects of rifampicin, pyrazinamide and their combination on mycobacteria with photometric measurement of turbidity]. Prax Klin Pneumol. 1983; 37(11):1167-70. View

14.

Snider Jr D, Good R, Kilburn J, Laskowski Jr L, Lusk R, Marr J . Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis. 1981; 123(4 Pt 1):402-6. DOI: 10.1164/arrd.1981.123.4.402. View

15.

Siddiqi S, Libonati J, MIDDLEBROOK G . Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 1981; 13(5):908-12. PMC: 273915. DOI: 10.1128/jcm.13.5.908-912.1981. View

16.

Zimmer B, DeYoung D, Roberts G . In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex. Antimicrob Agents Chemother. 1982; 22(1):148-50. PMC: 183690. DOI: 10.1128/AAC.22.1.148. View

17.

Heifets L . Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare. Am Rev Respir Dis. 1982; 125(1):43-8. DOI: 10.1164/arrd.1982.125.1.43. View

18.

Heifets L, Iseman M, Kanes W . Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods. Antimicrob Agents Chemother. 1985; 28(4):570-5. PMC: 180307. DOI: 10.1128/AAC.28.4.570. View

19.

Baron E, Young L . Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome. Diagn Microbiol Infect Dis. 1986; 5(3):215-20. DOI: 10.1016/0732-8893(86)90004-0. View

20.

ENGBAEK H, Vergmann B, Bentzon M . Lung disease caused by Mycobacterium avium/Mycobacterium intracellulare. An analysis of Danish patients during the period 1962-1976. Eur J Respir Dis. 1981; 62(2):72-83. View